A Growing Field With Significant Need for Innovation
Endoscopic oncology is entering an important period of growth. Advances in early cancer detection, minimally invasive treatment, cancer ablation, organ preservation, artificial intelligence, tissue acquisition, and palliative endoscopy are expanding the role of endoscopy across the cancer care continuum. At the same time, substantial unmet needs remain.
Clinicians need better tools to identify disease earlier, characterize lesions more accurately, obtain higher quality tissue, deliver targeted therapy, reduce procedural risk, preserve organ function, and improve the experience of patients living with cancer. Many existing technologies were not designed specifically for oncology, creating an opportunity for new devices, digital solutions, diagnostic platforms, and therapeutic technologies tailored to the needs of cancer care.
In many areas, endoscopic oncology represents both a growing market and an opportunity to make a meaningful difference for patients. Progress will require active engagement from medical device companies, biotechnology organizations, digital health leaders, engineers, entrepreneurs, investors, and other industry partners.
Why Industry Engagement Matters
The future of endoscopic oncology cannot be developed by clinicians alone. Industry brings essential expertise in engineering, product development, manufacturing, artificial intelligence, clinical research, regulatory strategy, commercialization, and global distribution.
When industry partners engage early with clinicians and researchers, innovation can be directed toward the problems that matter most in daily practice.
Follow us on social media

